TAKEDA PHARMACEUTICALS AMERICA, INC.
Entity uei:DDEVYUAXJ624 · UEI DDEVYUAXJ624
Obligations by fiscal year
Awards (7)
| 36C26024F0417↗ LANADELUMAB-FLYO 150MG/ML INJ, SYRINGE,2ML (TAKHZYRO) | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | May 20, 2024 – May 19, 2025 | $221K | — | 0 |
| 36C26124N0588↗ TAKHZYRO (LANADELUMAB-FLYO) 150MG/ML INJ,SYRINGE,2ML, NDC: 47783-0646-01 | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Apr 15, 2024 – May 15, 2024 | $216K | — | 0 |
| 36C26025F0061↗ BULK ADZYNMA 1500IU INJ,LYPHL | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jan 4, 2025 – Jan 3, 2026 | $194K | — | 0 |
| 36C26124N0169↗ CINRYZE C-1 | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 1, 2023 – Jan 31, 2024 | $130K | — | 0 |
| 36C26025F0279↗ MARIBAVIR 200MG TABS | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | May 28, 2025 – Sep 30, 2025 | $112K | — | 0 |
| 36C26124N0632↗ LANADELUMAB-FLYO (TAKHZYRO) 15OMG/ML INJ, SYRINGE, 2ML NDC: 47783-0646-01 | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | May 3, 2024 – Jun 6, 2024 | $111K | — | 0 |
| 36C26026P0420↗ GAMMAGARD LIQUID ERC - GLOBULIN,IMMUNE (IV) 10% INJ | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Apr 27, 2026 – Sep 30, 2026 | $108K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- TAKEDA PHARMACEUTICALS AMERICA, INC.
DDEVYUAXJ624· seen 21×